EC approves Merck’s Keytruda plus chemotherapy as neoadjuvant treatment for non-small cell lung cancer
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
Cipla completes transfer of Generics Business Undertaking
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Subscribe To Our Newsletter & Stay Updated